Immunology / Virology & Vaccines

#Immunology / Virology & Vaccines

Virus in a well – microplate-based assays for virology research

The COVID-19 pandemic has promoted global efforts to develop antiviral treatments and vaccines against SARS-CoV-2. The pandemic has put virology, a field of research that has been neglected for years, back on the map by Tobias Pusterla, BMG Labtech. In fact, the increase in occurrence and types of virus outbreaks… Read More

#Exclusive Content

#Covid-19 #Immunology / Virology & Vaccines

Swiss government authorises Moderna vaccine and secures 7.5 million doses

Swissmedic, the Swiss Agency for Therapeutic Products, has authorised the COVID-19 Moderna Vaccine in Switzerland. The authorisation is given according to the ordinary approvals procedure and is based on a rolling submission of data and the totality of scientific evidence shared by the company, including a data analysis from the… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Covid-19 #Immunology / Virology & Vaccines

Moderna vaccine becomes third COVID-19 to be approved by UK regulator

The COVID-19 vaccine developed by Moderna has been given regulatory approval for supply by the Medicines and Healthcare products Regulatory Agency (MHRA). This follows a thorough and rigorous assessment by the MHRA’s teams of scientists, including advice from the independent Commission on Human Medicines, which reviewed in depth all the… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Covid-19 #Immunology / Virology & Vaccines

Novavax seals agreement with Australia for 51 million doses of COVID-19 Vaccine

Novavax has executed an Advance Purchase Agreement with the Commonwealth of Australia for 51 million doses of NVX-CoV2373, Novavax’ COVID-19 vaccine candidate. This follows an agreement in principle that was announced in November 2020. NVX-CoV2373 is a recombinant protein vaccine adjuvanted with Novavax’ proprietary Matrix-M to enhance the immune response. Read More

#Covid-19 #Editor's Choice #News #Trending News

#Covid-19 #Immunology / Virology & Vaccines

European Commission authorises Moderna COVID-19 vaccine in Europe

The European Commission has granted a conditional marketing authorisation (CMA) for Moderna’s COVID-19 vaccine Moderna, allowing vaccination programs using the Moderna vaccine to be rolled out across the European Union. The authorisation is based upon the recommendation of the European Medicines Agency (EMA) for use of the COVID-19 Vaccine Moderna… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Covid-19 #Immunology / Virology & Vaccines #Life sciences #Oncology #Therapies

The life sciences industry has learned a lot from COVID-19, but there’s more to be done

By Dr Steve Arlington, President, The Pistoia Alliance COVID-19 has dealt the life sciences a host of challenges, but it’s also been the catalyst for positive change. As the industry has turned its resources towards developing critical vaccines and therapies, organisations, governments, regulators, researchers and academia have come together in… Read More

#Editor's Choice #Exclusive Content #News #Opinion

#Clinical trials #Immunology / Virology & Vaccines #Therapeutics

Peanut allergy biomarker study may lead to novel peanut vaccine candidate

Allergy Therapeutics, the specialty pharmaceutical company specialising in allergy vaccines, has announced that an ex-vivo biomarker study of blood samples from peanut allergy patients has begun at Imperial College London. The study aims to evaluate the group’s novel virus like particle (VLP) based peanut allergy vaccine candidate, to confirm its… Read More

#Editor's Choice #News

#Covid-19 #Immunology / Virology & Vaccines

WHO issues emergency use validation for COVID-19 vaccine

The World Health Organization (WHO) has listed the COVID-19 mRNA vaccine for emergency use, making the Pfizer/BioNTech vaccine the first to receive emergency validation from WHO since the outbreak began a year ago. The WHO’s Emergency Use Listing (EUL) opens the door for countries to expedite their own regulatory approval… Read More

#Covid-19 #Editor's Choice #News

#Covid-19 #Immunology / Virology & Vaccines

“A moment to celebrate British innovation”: Oxford AstraZeneca vaccine gets go-ahead

The UK Medicines and Healthcare products Regulatory Agency (MHRA) has provided authorisation for emergency supply of the Oxford University AstraZeneca COVID-19 vaccine for the active immunisation of individuals 18 years or older. The authorisation recommends two doses administered with an interval of between four and 12 weeks. This regimen was shown… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Covid-19 #Immunology / Virology & Vaccines

“A great day for British science”: MHRA approves Oxford COVID-19 vaccine

The UK government has accepted the recommendation from the Medicines and Healthcare products Regulatory Agency (MHRA) to authorise the emergency use of the ChAdOx1 nCoV-19 coronavirus vaccine in the UK. The Joint Committee on Vaccination and Immunisation (JCVI) will also publish its latest advice for the priority groups to receive… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Covid-19 #Immunology / Virology & Vaccines

COVID-19 vaccine: “That is how our country will begin to move forward,” says Fauci

The FDA has issued an Emergency Use Authorization (EUA) to Moderna, for its COVID-19 vaccine, which was co-developed with scientists at the NIH National Institute of Allergy and Infectious Diseases (NIAID) and Moderna. This partnership has enabled NIH and Moderna to develop a COVID-19 vaccine within a year that will… Read More

#Covid-19 #Editor's Choice #News #Trending News

#Antibody #Covid-19 #Immunology / Virology & Vaccines #T-Cells

Oxford vaccine stimulates broad antibody and T cell functions

Researchers from the University of Oxford have published further data from the Phase I/II clinical trials of the ChAdOx1 nCoV-19 coronavirus vaccine, evidencing the decision to move to a two-dose regimen in ongoing Phase III trials, and how ChAdOx1 nCov-19 is induces broad antibody and T cell functions. These findings… Read More

#Covid-19 #Editor's Choice #News #Trending News